PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Pharmaceuticals

Market Closed - Xetra 11:36:21 2024-04-26 am EDT 5-day change 1st Jan Change
22.2 EUR 0.00% Intraday chart for PharmaSGP Holding SE -0.89% -1.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 CI
PharmaSGP Holding SE Announces Changes to Dividend Policy CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023. CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PharmaSGP Completes EUR2 Million Share Buyback Program MT
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PharmaSGP Holding SE commences an Equity Buyback Plan, under the authorization approved on May 28, 2020. CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PharmaSGP Holding SE Reaffirms Earnings Guidance for the Year 2022 CI
PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022 CI
PharmaSGP Holding SE Approves Dividend CI
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PharmaSGP Holding SE Provides Revenues Guidance for the Financial Year 2022 CI
PharmaSGP Proposes Dividend for 2021 CI
PharmaSGP Announces Revenue Results for the Financial Year 2021 CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
PharmaSGP Holding SE Announces Financial Results for the First Half of 2021 CI
PharmaSGP Holding SE Raises Financial Forecast for Fiscal Year 2021 CI
PharmaSGP : GSK Closes Sale of Four OTC Brands to PharmaSGP MT
Certain Bearer Shares of PharmaSGP Holding SE are subject to a Lock-Up Agreement Ending on 20-JUN-2021. CI
GlaxoSmithKline : to Sell Four OTC Brands to PharmaSGP in $97 Million Deal MT
Chart PharmaSGP Holding SE
More charts
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.2 EUR
Average target price
37 EUR
Spread / Average Target
+66.67%
Consensus
  1. Stock Market
  2. Equities
  3. PSG Stock
  4. News PharmaSGP Holding SE
  5. PharmaSGP Completes EUR2 Million Share Buyback Program